How Xavier Becerra Reshaped U.S. Healthcare—and What’s Next

Published

Xavier Becerra’s name has become synonymous with the Biden administration’s healthcare agenda, a figure whose legal acumen and political savvy have positioned him at the forefront of one of America’s most contentious and consequential policy battles. As the current U.S. Secretary of Health and Human Services (HHS), Becerra has navigated a landscape marked by pandemic recovery, pharmaceutical price reforms, and the expansion of the Affordable Care Act (ACA). His career—spanning three decades in public service, from California’s Attorney General to his current role—offers a masterclass in how institutional power can be leveraged to address systemic inequities in healthcare access.

Yet Becerra’s influence extends beyond policy wonks and Capitol Hill. His tenure has forced a reckoning with long-standing debates: Can the ACA survive its legal and political challenges? How do rising drug prices intersect with Medicare’s future? And what does it mean for millions of Americans when a former prosecutor turns his skills toward reshaping an industry often criticized for prioritizing profits over patients? The answers lie not just in his legislative achievements but in the broader cultural and economic forces he’s either accelerated or resisted.

Critics argue that Becerra’s approach—rooted in incrementalism and bureaucratic pragmatism—lacks the boldness of past reforms, while supporters point to his ability to secure bipartisan wins in an era of deep polarization. What remains undeniable is that his leadership has injected urgency into conversations about healthcare affordability, mental health parity, and the role of government in safeguarding public health. The question now is whether his strategies will outlast his tenure—or if they’ll be remembered as a fleeting moment in a much larger, unresolved struggle.

xavier becerra

The Complete Overview of Xavier Becerra’s Role in U.S. Healthcare

Xavier Becerra’s appointment as HHS Secretary in March 2021 marked a return to the agency he had previously served under President Obama, where he played a pivotal role in implementing the Affordable Care Act. His reappointment under President Biden wasn’t merely symbolic; it signaled a commitment to doubling down on the ACA’s protections, expanding its reach, and addressing its critics—both in Congress and the courts. Becerra’s background as a former U.S. Representative (2013–2017) and California Attorney General (2011–2017) equipped him with a unique blend of legal expertise and legislative experience, allowing him to bridge the gap between theoretical policy and real-world execution.

His leadership has been defined by three interrelated priorities: defending the ACA against legal and political attacks, lowering prescription drug costs through Medicare negotiations, and accelerating healthcare equity initiatives, particularly for underserved communities. Unlike his predecessors, Becerra has framed these efforts not as partisan battles but as moral imperatives—language that resonates with both progressives and moderates. This strategic positioning has been crucial in securing modest but meaningful victories, such as the expansion of Medicaid in key states and the introduction of inflation rebates for Medicare beneficiaries. Yet, his approach has also drawn criticism for its cautious incrementalism, particularly from advocates who argue that more aggressive reforms—like a public option or single-payer—are necessary to address the system’s structural flaws.

Historical Background and Evolution

Becerra’s journey to HHS began in the crucible of California’s political landscape, where he served as Attorney General from 2011 to 2017. During this time, he became a vocal advocate for healthcare access, suing pharmaceutical companies over opioid distribution practices and defending the ACA against legal challenges. His tenure in Congress (2013–2017) further solidified his reputation as a healthcare hawk, where he co-authored the Affordable Insulin Now Act and pushed for expanded mental health services. These early experiences shaped his belief that healthcare reform required both legal and legislative tools—an approach he would later refine as HHS Secretary.

Table of Contents

The transition from California to Washington was seamless in some ways, but the federal stage presented new challenges. Becerra inherited an HHS grappling with the fallout of the COVID-19 pandemic, where his role in distributing vaccines and testing kits became a litmus test for his administrative skills. Unlike his predecessor, Alex Azar, who often framed healthcare issues through a market-based lens, Becerra adopted a more interventionist stance, using the Department’s regulatory authority to cap insulin prices for Medicare patients and negotiate drug prices directly. This shift reflected a broader ideological realignment within the Democratic Party, where the emphasis on government-led solutions gained traction in the wake of the pandemic’s exposure of the healthcare system’s vulnerabilities.

Core Mechanisms: How It Works

Becerra’s policy toolkit relies on three core mechanisms: litigation, legislation, and administrative action. His use of litigation—most notably in defending the ACA against the Texas v. U.S. lawsuit—demonstrated how legal challenges could be weaponized to preserve existing protections. Meanwhile, his legislative efforts, such as the Inflation Reduction Act (IRA), leveraged narrow majorities in Congress to achieve incremental but significant reforms, like allowing Medicare to negotiate drug prices for the first time in history. Finally, his administrative actions—such as expanding telehealth services and tightening enforcement against price-gouging—highlighted the power of executive authority in shaping healthcare outcomes without new laws.

The synergy between these mechanisms has been critical to Becerra’s success. For example, the IRA’s drug pricing provisions were the culmination of years of advocacy, legal battles, and administrative groundwork. Similarly, his push for Medicaid expansion in non-expansion states relied on a mix of federal incentives, state partnerships, and targeted litigation. This multi-pronged approach has allowed him to achieve results even in a politically divided environment, though it has also drawn criticism for its reliance on piecemeal solutions rather than systemic overhaul.

Key Benefits and Crucial Impact

Xavier Becerra’s tenure has yielded tangible benefits for millions of Americans, particularly in areas where the healthcare system has historically failed: affordability, access, and equity. The most immediate impact has been on prescription drug costs, where the IRA’s provisions are projected to save Medicare beneficiaries over $100 billion by 2030. Similarly, his efforts to cap insulin prices at $35 a month for Medicare patients have provided relief to diabetics who previously faced exorbitant out-of-pocket expenses. These reforms, while incremental, represent a seismic shift in how the federal government engages with pharmaceutical companies—a departure from decades of industry-friendly policies.

Beyond cost savings, Becerra has prioritized expanding healthcare access, particularly for marginalized communities. His push for Medicaid expansion in states like Idaho and Nebraska—achieved through a mix of federal pressure and state-level negotiations—has brought coverage to hundreds of thousands of low-income Americans. Additionally, his focus on mental health parity and maternal healthcare has addressed gaps left by previous administrations. Yet, the full extent of his impact will only be measured in years to come, as many of his initiatives are still in their early stages of implementation.

"Healthcare is a right, not a privilege." —Xavier Becerra, 2021 HHS Confirmation Hearing

Major Advantages

  • Drug Price Negotiations: The IRA’s allowance for Medicare to negotiate prices with drugmakers marks the first federal intervention in pharmaceutical pricing since the 1930s, with potential savings exceeding $200 billion over a decade.
  • ACA Stabilization: Becerra’s legal defenses and administrative actions have preserved key ACA provisions, including protections for pre-existing conditions and essential health benefits, despite repeated Republican-led repeal efforts.
  • Medicaid Expansion: Through targeted outreach and federal incentives, Becerra has helped expand Medicaid in several holdout states, covering over 4 million additional Americans.
  • Healthcare Equity Initiatives: His focus on maternal health, mental health parity, and LGBTQ+ healthcare access has addressed long-standing disparities in underserved communities.
  • Pandemic Recovery Leadership: As HHS Secretary during COVID-19, Becerra oversaw vaccine distribution and testing programs, preventing millions of infections and deaths through federal coordination.

xavier becerra - Ilustrasi 2

Comparative Analysis

Policy Area Xavier Becerra’s Approach
Prescription Drug Pricing Federal negotiation authority (IRA), insulin price caps, and litigation against price-gouging.
ACA Defense Legal challenges (Texas v. U.S.), administrative rulemaking, and bipartisan outreach to stabilize markets.
Medicaid Expansion State partnerships, federal incentives, and targeted litigation to pressure non-expansion states.
Healthcare Equity Focus on maternal health, mental health parity, and LGBTQ+ protections through HHS grants and regulations.

The next phase of Becerra’s tenure will likely be shaped by two competing forces: the political headwinds facing the Biden administration and the evolving healthcare landscape. On the policy front, his push for further drug price reforms—such as expanding Medicare negotiation authority to additional medications—will be a key battleground. Similarly, his efforts to integrate behavioral health into primary care could redefine how mental health services are delivered, particularly in underserved areas. Technologically, advancements in telehealth and AI-driven diagnostics may accelerate under his leadership, though regulatory hurdles remain.

Yet, the biggest wildcard is the 2024 election. If Republicans regain control of Congress, Becerra’s ability to advance his agenda will depend on administrative actions and legal strategies rather than legislative cooperation. Conversely, a Democratic sweep could unlock more ambitious reforms, such as a public option or expanded Medicare benefits. Regardless of the political outcome, Becerra’s legacy will hinge on whether his incremental approach can sustain momentum for systemic change—or if future leaders will need to adopt more radical solutions to fix America’s broken healthcare system.

xavier becerra - Ilustrasi 3

Conclusion

Xavier Becerra’s impact on U.S. healthcare is a study in the art of the possible within the constraints of modern governance. His career reflects a pragmatic approach to reform—one that prioritizes achievable wins over ideological purity. While critics may dismiss his strategies as too cautious, his detractors often overlook the sheer scale of the challenges he’s tackled: defending the ACA, lowering drug prices, and expanding access in a polarized political environment. The results, while not revolutionary, have been meaningful for millions of Americans who now have better insurance, lower costs, and greater protections.

As the healthcare landscape continues to evolve, Becerra’s tenure will be remembered as a bridge between the Obama-era reforms and whatever comes next. Whether his policies endure or are superseded by future innovations, his influence on the debate over healthcare’s role in American society is undeniable. The question now is not whether his work will matter, but how deeply it will reshape the system for generations to come.

Comprehensive FAQs

Q: What was Xavier Becerra’s role before becoming HHS Secretary?

A: Before leading HHS, Becerra served as California Attorney General (2011–2017) and as a U.S. Representative (2013–2017), where he focused on healthcare access, opioid litigation, and ACA defense.

Q: How has Becerra addressed prescription drug prices?

A: Through the Inflation Reduction Act, Becerra secured Medicare’s first-ever authority to negotiate drug prices, capped insulin costs at $35/month for seniors, and launched lawsuits against price-gouging pharmaceutical companies.

Q: What is Becerra’s stance on the Affordable Care Act?

A: Becerra has been a staunch defender of the ACA, using litigation (e.g., Texas v. U.S.) and administrative actions to preserve its protections, including pre-existing condition coverage and essential health benefits.

Q: How has Becerra expanded Medicaid?

A: He’s used a mix of federal incentives, state partnerships, and targeted legal pressure to encourage Medicaid expansion in holdout states like Idaho and Nebraska, covering over 4 million additional Americans.

Q: What are the biggest challenges facing Becerra’s healthcare agenda?

A: Political polarization, legal challenges to the ACA, and the need for bipartisan support on drug pricing and Medicare reforms remain his greatest hurdles.

Q: How does Becerra’s approach compare to past HHS Secretaries?

A: Unlike market-focused predecessors like Alex Azar, Becerra emphasizes government intervention—through negotiation, litigation, and regulatory action—to lower costs and expand access.

Q: What’s next for Becerra in healthcare policy?

A: Future priorities include expanding Medicare drug negotiations, integrating behavioral health into primary care, and navigating post-election policy shifts under potential Republican control.